The goal of this component will be to determine how tumor cell death or growth is controlled by the LTbeta receptor (LTbetaR). This recently defined member of the TNF receptor family binds to the lymphotoxin alphabeta complex (LTalphabeta), a membrane-anchored cytokine expressed by cytotoxic T lymphocytes (CTL). The LTbetaR appears to play a dual role in the immune system, in host defense mechanisms against viruses such as Epstein-Barr virus (EBV), and in the development of peripheral lymphoid organs. Receptor associated proteins that bind to the cytoplasmic face of LTbetaR are hypothesized to be part of the active signaling complex. A novel RING/zinc finger protein, termed TRAF3 (formerly LAP-1), binds to the LTbetaR and the EBV protein LMP-1, demonstrating a molecular link between the transforming action of EBV with the signal transduction pathways of the LTbetaR. We will address whether the formation of LTbetaR and TRAF3 complex is critical for inducing tumor cell death. Sensitive and resistant clones of the U937 monocytic leukemia and HT-29 adenocarcinoma, characterized for expression of receptors, TRAFs, and cell death responses, will serve as tissue culture models for LTbetaR signaling. Negative sense, dominant negative mutations and direct competitive antagonists of LTbeta and TRAF3 interactions will be introduced into these cell lines and the responses to ligands or agonist anti-LTbetaR antibodies will be measured. Inhibition of cell death by uncoupling TRAF3 binding to LTbetaR will provide evidence that TRAF3 is a regulator of cell death. These two model cell lines will allow for parallel study of cell death pathways induced via related receptors, Fas and TNFR60. A molecular genetic approach will be used to determine whether known proteins, such as sphingomyelinase, can serve to directly couple LTbetaR to cell death. Alternatively, other unidentified proteins that link LTbetaR-TRAF complex will be identified by the two-hybrid system and tested for their functional roles using dominant negative mutants in the U937 and HT-29 cell lines. Finally, mice deleted for LTbetaR gene will be engineered to determine the relationship between cell death in immune responses and for development of lymph nodes. These studies will provide new understanding of the LTbetaR in host defense against persistent viruses and human cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA069381-02
Application #
6237661
Study Section
Project Start
1997-07-01
Project End
1998-06-30
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Sanford-Burnham Medical Research Institute
Department
Type
DUNS #
009214214
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Xu, X-P; Zhai, D; Kim, E et al. (2013) Three-dimensional structure of Bax-mediated pores in membrane bilayers. Cell Death Dis 4:e683
Chipuk, Jerry E; McStay, Gavin P; Bharti, Archana et al. (2012) Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis. Cell 148:988-1000
Fujikura, D; Ito, M; Chiba, S et al. (2012) CLIPR-59 regulates TNF-?-induced apoptosis by controlling ubiquitination of RIP1. Cell Death Dis 3:e264
Garrison, Jason B; Correa, Ricardo G; Gerlic, Motti et al. (2011) ARTS and Siah collaborate in a pathway for XIAP degradation. Mol Cell 41:107-16
Lu, Jennifer V; Weist, Brian M; van Raam, Bram J et al. (2011) Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity. Proc Natl Acad Sci U S A 108:15312-7
Ponder, Elizabeth L; Albrow, Victoria E; Leader, Brittany A et al. (2011) Functional characterization of a SUMO deconjugating protease of Plasmodium falciparum using newly identified small molecule inhibitors. Chem Biol 18:711-21
Timmer, John C; Salvesen, Guy S (2011) N-terminomics: a high-content screen for protease substrates and their cleavage sites. Methods Mol Biol 753:243-55
Oberst, Andrew; Dillon, Christopher P; Weinlich, Ricardo et al. (2011) Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471:363-7
Leverrier, S; Salvesen, G S; Walsh, C M (2011) Enzymatically active single chain caspase-8 maintains T-cell survival during clonal expansion. Cell Death Differ 18:90-8
Krajewska, Maryla; You, Zerong; Rong, Juan et al. (2011) Neuronal deletion of caspase 8 protects against brain injury in mouse models of controlled cortical impact and kainic acid-induced excitotoxicity. PLoS One 6:e24341

Showing the most recent 10 out of 192 publications